Category: Carestream Health Inc.
U.K. healthcare regulators issue a new warning on a decade-old concern for certain Carestream Health dental X-ray units.
Healthcare regulators in the U.K. revived a 10-year-old equipment concern regarding certain Carestream Health intra-oral dental X-ray units, warning that there may be devices out there that haven't received necessary "modification" to mitigate a falling equipment risk.
Life science companies led a surge of initial public offerings during the 2nd quarter, logging the largest number of biotech IPOs by venture-backed firms since the turn of the century.
The number of venture-backed life science companies going public neared a peak set in 2000 during the 2nd quarter, raising $2.2 billion and doubling the volume and value of IPOs from the 1st quarter, according to the National Venture Capital Assn. and Thomson Reuters.
There were also 83 venture-backed acquisitions during the quarter, down 59% compared with Q2 2012, according to the groups' Exit Poll report.
Private equity players Bain Capital, Carlyle Group and KKR & Co. are in the hunt for medical device company Carestream, said to be on the auction block for up to $3.5 billion.
At least 5 major private equity players are vying for medical device company Carestream Health, including Bain Capital, Carlyle Group and KKR & Co., according to Reuters.
Onex Corp. is hoping to unload Carestream, formed in the 2007 spinout of Eastman Kodak Co.'s healthcare business, for up to $3.5 billion, the news service reported.
Novation picks up new product lines from Teleflex, Covidien and others.
Angel Medical Systems raises nearly $28 million for its ischemia monitoring device, designed to give early warning of an incipient heart attack.
Angel Medical Systems said it's closed a funding round worth $28 million for its AngelMed Guardian implant, designed to detect the early heart problems that can lead to heart attacks and alert patients to seek medical care.
The round included existing backers and a new contribution from SOAM Angel Partners, which added principal Dr. Victor Whitman to Angel Medical's board, according to a press release.
Cleveland HeartLab raises nearly $15 million for its CardioMPO test for cardiac inflammation.
Cleveland HeartLab pulled in $14.7 million in equity financing for its proprietary test for cardiac inflammation, according to a regulatory filing.
The CardioMPO test was developed by Dr. Stanley Hazen, director of the Cleveland Clinic's center for cardiovascular diagnostics and prevention.
Cleveland HeartLab closed a $3 million round in 2010, with backers including Glengary and Second Generation Ltd.